ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Cancergrams Cost $840 Year For All

December 2, 1977

ACS Presents Awards To Anti-Tobacco Activists.

July 21, 2006

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

Peter Jones begins term as AACR president-elect. New directors elected.

April 2, 2004